Production (Stage)
Axsome Therapeutics, Inc.
AXSM
$105.07
$0.720.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 300.91M | 315.35M | 327.34M | 315.66M | 331.44M |
| Total Receivables | 161.40M | 142.00M | 124.10M | 120.34M | 101.43M |
| Inventory | 16.32M | 15.73M | 14.27M | 15.22M | 15.58M |
| Prepaid Expenses | 16.01M | 11.98M | 13.41M | 11.81M | 12.03M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 494.63M | 485.06M | 479.11M | 463.03M | 460.49M |
|
|
|||||
| Total Current Assets | 494.63M | 485.06M | 479.11M | 463.03M | 460.49M |
| Net Property, Plant & Equipment | 24.07M | 5.97M | 6.41M | 6.80M | 7.22M |
| Long-term Investments | 12.04M | 12.04M | 12.04M | 12.04M | 12.04M |
| Goodwill | 12.04M | 12.04M | 12.04M | 12.04M | 12.04M |
| Total Other Intangibles | 45.32M | 46.89M | 48.50M | 50.11M | 51.70M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 20.61M | 18.53M | 15.39M | 16.26M | 14.28M |
| Total Assets | 596.67M | 568.50M | 561.46M | 548.23M | 545.73M |
|
|
|||||
| Total Accounts Payable | 85.66M | 72.00M | 64.25M | 61.34M | 53.79M |
| Total Accrued Expenses | 146.42M | 145.61M | 120.40M | 115.57M | 82.08M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.27M | 3.26M | 2.91M | 2.62M | 1.79M |
| Total Finance Division Other Current Liabilities | 9.56M | 9.25M | 8.62M | 7.04M | 6.39M |
| Total Other Current Liabilities | 9.56M | 9.25M | 8.62M | 7.04M | 6.39M |
| Total Current Liabilities | 243.91M | 230.10M | 196.19M | 186.57M | 144.05M |
|
|
|||||
| Total Current Liabilities | 243.91M | 230.10M | 196.19M | 186.57M | 144.05M |
| Long-Term Debt | 181.38M | 180.71M | 180.00M | 179.33M | 178.69M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 27.59M | 8.99M | 9.39M | 9.85M | 8.96M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 90.59M | 91.68M | 82.98M | 69.62M | 70.00M |
| Total Liabilities | 543.47M | 511.48M | 468.56M | 445.37M | 401.69M |
|
|
|||||
| Common Stock & APIC | 1.24B | 1.18B | 1.14B | 1.09B | 1.05B |
| Retained Earnings | -1.18B | -1.12B | -1.05B | -983.27M | -903.93M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 53.21M | 57.02M | 92.90M | 102.85M | 144.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 53.21M | 57.02M | 92.90M | 102.85M | 144.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 53.21M | 57.02M | 92.90M | 102.85M | 144.04M |
|
|
|||||